Position in ICLR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$579,496
+$210,445 QoQ
Shares Held
3,336
+0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#233
of 422 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $21,207,266 across 19 Diagnostics & Research names. ICLR ranks #12 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,918 | $5,975,208 | |
| 2 | DHR |
Danaher Corp /De/
|
15,391 | $2,931,677 | |
| 3 | LH |
Labcorp Holdings Inc.
|
7,651 | $2,142,280 | |
| 4 | A |
Agilent Technologies, Inc.
|
9,423 | $1,251,657 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,125 | $1,118,685 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
5,581 | $1,078,360 | |
| 7 | ILMN |
Illumina, Inc.
|
5,103 | $897,260 | |
| 8 | NEO |
Neogenomics Inc
|
60,940 | $889,114 |
All Filings in ICLR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579,496 | 3,336 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $369,051 | 3,335 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $444,799 | 2,441 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $447,825 | 2,559 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $399,260 | 2,745 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,051,164 | 6,007 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,286,780 | 6,136 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,562,104 | 5,437 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,741,325 | 5,555 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||